Media headlines about Aspen Aerogels (NYSE:ASPN) have trended somewhat positive on Tuesday, Accern reports. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aspen Aerogels earned a news impact score of 0.09 on Accern’s scale. Accern also assigned news articles about the construction company an impact score of 46.1623586792219 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:
- Zacks Investment Research Downgrades Aspen Aerogels, Inc. (ASPN) to Hold (americanbankingnews.com)
- Aspen Aerogels, Inc. (ASPN) Receives Average Rating of “Hold” from Brokerages (americanbankingnews.com)
- ETFs with exposure to Aspen Aerogels, Inc. : September 13, 2017 (finance.yahoo.com)
- Aspen Aerogels, Inc. (ASPN) Raised to “Buy” at Zacks Investment Research (americanbankingnews.com)
Shares of Aspen Aerogels (NYSE:ASPN) traded up 1.70% on Tuesday, reaching $4.19. 10,952 shares of the company’s stock were exchanged. The firm’s market cap is $86.24 million. The company has a 50 day moving average price of $4.35 and a 200 day moving average price of $4.27. Aspen Aerogels has a one year low of $3.61 and a one year high of $6.71.
Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, August 3rd. The construction company reported ($0.23) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.24) by $0.01. The business had revenue of $25.10 million for the quarter, compared to analysts’ expectations of $24.79 million. Aspen Aerogels had a negative return on equity of 20.95% and a negative net margin of 22.22%. The company’s revenue for the quarter was down 9.4% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.02) EPS. Analysts expect that Aspen Aerogels will post ($0.86) EPS for the current fiscal year.
Several research analysts recently weighed in on the stock. Zacks Investment Research cut shares of Aspen Aerogels from a “buy” rating to a “hold” rating in a research report on Monday. ValuEngine cut shares of Aspen Aerogels from a “sell” rating to a “strong sell” rating in a research report on Friday, July 28th. Finally, Citigroup Inc. increased their price target on shares of Aspen Aerogels from $4.50 to $4.75 and gave the company a “neutral” rating in a research report on Tuesday, May 30th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. Aspen Aerogels currently has an average rating of “Hold” and an average price target of $6.38.
ILLEGAL ACTIVITY NOTICE: This article was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.chaffeybreeze.com/2017/09/19/aspen-aerogels-aspn-receives-media-impact-rating-of-0-09.html.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
Receive News & Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related companies with MarketBeat.com's FREE daily email newsletter.